Objectives: To compare the response of mouse osteoblast (MC3T3-E1 cells) to advanced platelet-rich fibrin (APRF) and advanced platelet-rich fibrin plus (APRF+). Methods: Blood was collected from eight volunteers, 25 - 38 years of age (four males and four females) to prepare platelet concentrates APRF (1,300 rpm, 14 minutes), APRF+ (1,300 rpm, 8 minutes). The exudates were collected from both platelet concentrates at day 1, 3, 7 and 14. The level of TGF-β1 from exudates were quantified using an ELISA. MC3T3-E1 cells were cultured with the exudates. The cultured cells were tested with MTT assays, alkaline phosphatase (ALP) staining and mineralization, which were analyzed on day 7 and again on day 14. Results: APRF and APRF+ continuously released TGF-β1 during 14-days period. Only exudates collected at day 1 showed significantly difference of ALP staining between APRF and APRF+ group on day 14 of observation. On day 7 of mineralization assays, cells treated with exudates from APRF+ collected at day 14 resulted in the highest level of mineralization within APRF+ group. On day 14 of mineralization assays, cells treated with exudates from APRF collected at day 7 showed the highest level of mineralization within APRF group. Conclusions: APRF+ released TGF-β1 at day 14 significantly higher than day 1. On day 14 of mineralization, cells treated with exudates from APRF+ collected at day 14 showed significantly higher mineralization than APRF collected at the same time point.
No takes yet. Share an insight, caveat, or question.
Domprapagon et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: